Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Merck
QuintilesIMS
Chinese Patent Office
Colorcon
Dow
Accenture
US Department of Justice

Generated: April 21, 2018

DrugPatentWatch Database Preview

HEPSERA Drug Profile

« Back to Dashboard

When do Hepsera patents expire, and what generic alternatives are available?

Hepsera is a drug marketed by Gilead and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has sixty-four patent family members in twenty-five countries.

The generic ingredient in HEPSERA is adefovir dipivoxil. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the adefovir dipivoxil profile page.
Drug patent expirations by year for HEPSERA
Synonyms for HEPSERA
((((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy))bis(methylene) bis(2,2-dimethylpropanoate)
(((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate
(((2-(6-AMINO-9H-PURIN-9-YL)ETHOXY)METHYL)PHOSPHORYL)BIS(OXY)BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE)
((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate
(2-(6-AMINOPURIN-9-YL)ETHOXYMETHYL-(2,2-DIMETHYLPROPANOYLOXYMETHOXY)PHOSPHORYL)OXYMETHYL2,2-DIMETHYLPROPANOATE
[({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate
[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
142340-99-6
2,2-dimethylpropanoic acid [2-(6-aminopurin-9-yl)ethoxymethyl-[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]oxymethyl ester
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3-phosphanon-1-yl pivalate (non-preferred
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3?5-phosphanon-1-yl 2,2-dimethylpropanoate
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3lambda~5~-phosphanon-1-yl 2,2-dimethylpropanoate
340A996
9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine
9-[2-[Bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine
9-[2-[BIS[(PIVALOYLOXY)METHOXY]PHOSPHINYL]METHOXY]ETHYL]ADENINE
A807894
AB0012816
AB01274706_02
AB01274706-01
AB07592
AB2000245
AC-1693
AC1L1U36
adefovir depivoxil
Adefovir di(pivaloyloxymethyl) ester
ADEFOVIR DIPIVOXIL
Adefovir Dipivoxil (Preveon, Hepsera)
Adefovir dipivoxil (USAN)
Adefovir dipivoxil [USAN]
Adefovir dipivoxil, Antibiotic for Culture Media Use Only
Adefovir dipivoxyl
Adefovir pivoxil
Adefovir pivoxil (JAN)
Adefovirdipivoxl
AKOS005145737
Ambap142340-99-6
AN-6719
ANW-43238
API0001387
ARONIS27063
B2222
BC206225
BCP0726000157
BCP9000232
BCPP000434
bis-POM PMEA
Bis-POM PMEA, Adefovir Dipivoxil
Bis-POM PMEA, Preveon, Hepsera, Adefovir Dipivoxil
Bis-POM PMEA;Preveon;Hepsera;Preveon;Hepsera
Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine
BIS(PIVALOYLOXYMETHYL)-9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE
Bis(POM)-PMEA
Bis(pom)PMEA
C-22950
C20H32N5O8P
CA0117
CAS-142340-99-6
CC-23770
CHEMBL922
CS-2240
CTK8B3813
D01655
D0ML1F
DB00718
DIPIVOXIL
DR003071
DSSTox_CID_26487
DSSTox_GSID_46487
DSSTox_RID_81658
DTXSID5046487
FT-0082875
FT-0631164
GP5823
GS 0840
GS 840
GS-0840
GS-3604
GS-840
HE310667
Hepsera (TM)
Hepsera (TN)
HMS3604F09
HMS3655I04
HY-B0255
I06-1150
I14-3234
KS-00000L27
KS-000048K6
LS-173141
MCULE-6257358029
MFCD00869897
MLS003915635
MLS004774124
NCGC00164624-01
NCGC00164624-02
NCGC00164624-03
Piv2PMEA
Preveon
Preveon (TN)
Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester
Propanoic acid,2,2-dimethyl-(((2-(6-amino-9H-purin-9-yl)ehtoxy)mehtyl)phosphinyldiene)bis(oxymehtylene)ester
PubChem14224
Q-101927
RP17773
RTC-070886
s1718
SCHEMBL29729
SMR002530072
SR-01000931258
SR-01000931258-2
STL257088
TC-070886
TL8000938
Tox21_112243
Tox21_112243_1
U6Q8Z01514
UNII-U6Q8Z01514
W-2203
YouHeDing
ZINC3930376

US Patents and Regulatory Information for HEPSERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HEPSERA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for HEPSERA
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 10 mg ➤ Subscribe 2010-06-08

Supplementary Protection Certificates for HEPSERA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00131 Netherlands ➤ Try a Free Trial PRODUCT NAME: ADEFOVIR DIPIVOXIL, DESGEWENST IN DE VORM VAN FARMACEUTISCH AANVAARDBARE ZUURADDITIE ZOUTEN, METAALZOUTEN EN SOLVATEN HIERVAN; NAT. REGISTRATION NO/DATE: EU/1/03/251/001 20030306; FIRST REGISTRATION: EU/1/03/251/001 20030306
C/GB03/030 United Kingdom ➤ Try a Free Trial PRODUCT NAME: ADEFOVIR DIPIVOXIL; REGISTERED: UK EU/1/03/251/001 20030306
C0034 France ➤ Try a Free Trial PRODUCT NAME: ADEFOVIR DIPIVOXIL; REGISTRATION NO/DATE: EU/1/03/251/001 20030306
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fuji
Covington
Julphar
Moodys
Fish and Richardson
Farmers Insurance
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.